0.192? Sorry I’ve been in this game way too long. Started in 2014 and still on the same phase 3 trial. Hope the article brings you what you hope for though.
With all the articles that have been written nothing makes this stock move and tomorrow article will be the same. The only thing is unblinded information on the trial.